Connect
MJA
MJA

Troponin testing: an audit in three metropolitan hospitals

Richard X Davey
Med J Aust 2003; 179 (2): 81-83.

Summary

Objective: To audit the appropriateness of use of a troponin I assay in three hospitals.

Design: Cross-sectional survey of use of a troponin assay.

Setting: Three hospitals in Melbourne, Victoria, each with an emergency department and a coronary care unit.

Participants: Patients for whom a troponin I assay was requested between 1 and 7 May 2002, 27–42 months after introduction of the assay.

Interventions: User-focused dissemination of relevant information, including protocols for use, from opinion leaders when the assay was introduced; continuous reinforcement of information in pathology reports.

Main outcome measures: Adherence to protocol for assay use.

Results: Troponin assays were requested for 333 patients during 351 symptom episodes. A single assay was used in 194 symptom episodes (55%), and serial assays in 157 (45%); proportions were statistically indistinguishable across all three hospitals (χ2; P = 0.71). Of the 194 single assays, 13 (7%) diagnosed a myocardial infarction. Serial troponin testing in all three hospitals followed the suggested protocol, with mean time between serial assays being more than 6 hours at all hospitals.

Conclusions: Adherence to the protocol for serial troponin assay intervals was adequate, but single troponin assays were used extensively and probably inappropriately.

Please login with your free MJA account to view this article in full

  • Richard X Davey

  • Pathology Department, Western Hospital, Footscray, VIC.

Correspondence: 

Competing interests:

None identified.

  • 1. Apple FS, Wu AHB. Myocardial infarction redefined: Role of cardiac troponin testing. Clin Chem 2001; 47: 377-379.
  • 2. Panteghini M. Acute coronary syndrome. Biochemical strategies in the troponin era. Chest 2002; 122: 1428-1435.
  • 3. Collinson PO, Boa FG, Gaze DC. Measurement of cardiac troponins. Ann Clin Biochem 2001; 38: 423-449.
  • 4. Alpert JS, Thygesen K, Antman E, Bassand JP. The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined — a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000; 36: 959-969.
  • 5. Wu AHB, Apple FS, Warshaw MM, editors. Recommendations for the use of cardiac markers in coronary artery disease. Washington: American Association for Clinical Chemistry Press, 1999.
  • 6. Wu A, for the NACB Committee. Draft standard of laboratory practice: use of cardiac markers in coronary artery disease. Considered 1998 Aug 4 and 5, at the Annual Scientific Meeting of the American Association for Clinical Chemistry. Washington: AACC Press, 1998.
  • 7. StataCorp. Stata Statistical Software: Release 6. College Station TX: Stata Press, 1999.
  • 8. Pauker SG, Kassirer JP. The threshold approach to clinical decision making. N Engl J Med 1980; 302: 1109-1117.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.